Dow Down 0.18% Nasdaq Up 0.39%

PDL BioPharma, Inc. (PDLI)

-NasdaqGS
10.26 Up 0.17(1.68%) 3:59PM EDT
|After Hours : 10.26 0.00 (0.00%) 4:24PM EDT
Prev Close:10.09
Open:10.17
Bid:10.01 x 800
Ask:10.20 x 100
1y Target Est:7.67
Beta:0.51
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:9.95 - 10.26
52wk Range:7.38 - 10.26
Volume:4,472,113
Avg Vol (3m):2,284,500
Market Cap:1.65B
P/E (ttm):5.91
EPS (ttm):1.74
Div & Yield:0.60 (6.60%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PDLI

Comparison

Symbol% ChgMkt Cap
PDLIUp 1.68%1.65B
AMGNDown 1.02%104.80B
SGENDown 3.16%5.26B
XOMADown 1.60%461.50M

Key Statistics

Forward P/E (1 yr):4.58
P/S (ttm):3.69
Ex-Dividend Date:03-Dec-14

Analysts

Annual EPS Est (Dec-14) :1.98
Quarterly EPS Est (Sep-14) :0.50
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):0.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

PDL BioPharma, Inc. manages a portfolio of patents and royalty assets. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback